Organogenesis Holdings (ORGO) Balance Sheet: Assets & Liabilities

Organogenesis Holdings (ORGO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Organogenesis Holdings reported total assets of $598.73M and total liabilities of $164.81M. Shareholders' equity was $433.92M, up 12.6% from $385.32M a year earlier. Total debt stood at $132.84M against $93.68M in cash and short-term investments, a net debt position of $39.16M. That puts debt-to-equity at 0.31, compared with 0.03 a year earlier.

Organogenesis Holdings Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Organogenesis Holdings Inc. (ORGO) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	93.68	135.57	103.84	102.48	113.93	84.39	60.17	21.29	0.13
Short-Term Investments	0.00	0.31	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	93.68	135.88	104.71	102.48	113.93	84.39	60.17	21.29	0.13
Accounts Receivable	217.45	109.86	82.00	89.45	82.46	56.80	39.36	34.08	0.00
Inventory	29.63	26.22	28.25	24.78	25.02	27.80	22.92	13.32	0.00
Other Current Assets	21.43	13.71	10.45	5.90	0.11	5.35	3.15	2.44	0.17
Total Current Assets	362.19	285.94	225.04	222.61	226.98	174.34	125.60	71.13	0.29
Non-Current Assets
Property, Plant & Equipment (Net)	159.46	126.24	156.35	145.66	128.30	55.79	47.18	39.62	0.00
Long-Term Investments	0.00	0.00	15.87	0.00	0.00	0.00	0.00	0.48	312.50
Goodwill	28.77	28.77	28.77	28.77	28.77	28.77	25.54	25.54	0.00
Intangible Assets	9.15	12.47	15.87	20.79	25.67	30.62	20.80	26.09	0.00
Other Non-Current Assets	9.20	44.47	33.99	1.52	1.54	0.67	1.44	0.58	0.00
Total Non-Current Assets	236.54	211.95	234.98	226.75	216.28	115.87	95.09	92.55	312.50
Total Assets	598.73	497.89	460.03	449.36	443.26	290.22	220.69	163.68	312.79
Current Liabilities
Accounts Payable	31.95	39.45	30.72	32.33	29.34	23.38	28.39	19.17	19.05
Short-Term Debt	18.64	9.11	5.49	16.25	2.66	20.29	3.06	4.78	5.47
Current Portion of Long-Term Debt	9.44	1.17	5.49	4.54	4.09	16.67	-	-	-
Accrued Liabilities	1.70	31.22	30.07	5.78	8.12	21.91	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	30.42	0.00
Other Current Liabilities	49.53	3.95	3.59	23.82	1.14	24.55	28.45	37.44	-20.59
Total Current Liabilities	100.12	77.48	80.51	75.02	82.71	68.22	59.89	66.39	3.93
Non-Current Liabilities
Long-Term Debt	114.20	0.72	60.75	107.55	70.77	64.49	97.55	49.22	12.39
Other Non-Current Liabilities	-49.51	0.89	1.21	1.12	1.56	15.71	7.66	0.90	-1.54
Total Non-Current Liabilities	64.69	49.28	100.85	108.67	119.22	80.19	105.21	50.25	10.85
Total Liabilities	164.81	112.57	181.36	183.69	201.92	148.41	165.10	116.64	14.78
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	293.01
Retained Earnings	-3.08	-40.11	-40.97	-45.30	-60.83	-155.04	-171.01	-130.24	-2.33
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-293.01
Additional Paid-in Capital	303.19	302.99	319.62	310.96	302.16	296.83	226.58	177.27	300.34
Shares Outstanding	126.95	125.73	131.32	130.92	128.68	-	-	-	-
Total Stockholders' Equity	433.92	385.32	278.66	265.67	241.34	141.81	55.58	47.04	298.01
Total Liabilities & Equity	598.73	497.89	460.03	449.36	443.26	290.22	220.69	163.68	312.79

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Organogenesis Holdings Balance Sheet

How much debt does Organogenesis Holdings have?

Organogenesis Holdings had total debt of $132.84M as of Dec 31, 2025, against $93.68M in cash and short-term investments. Its debt-to-equity ratio was 0.31. Total debt was $9.83M a year earlier.

What are Organogenesis Holdings's total assets?

Organogenesis Holdings reported total assets of $598.73M as of Dec 31, 2025, up 20.3% from $497.89M a year earlier. Total liabilities were $164.81M.

What is Organogenesis Holdings's shareholders' equity?

Organogenesis Holdings's shareholders' equity was $433.92M as of Dec 31, 2025, or about $3.42 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition